Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation - Fig 1

Proportion of subjects who developed CAC over four years according to baseline NAFLD status (A) and hs-CRP levels (B). CAC, coronary artery calcification; NAFLD, non-alcoholic fatty liver disease; hs-CRP, high-sensitivity C-reactive protein.